Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Hitoshi Nishitani"'
Autor:
Kohei Akiyoshi, Yuriko Ito, Tetsuya Hamaguchi, Tetsuji Terazawa, Hitoshi Nishitani, Akihiro Nakamoto, Takako Eguchi Nakajima, Hironobu Hashimoto, Yasuhiro Shimada, Ken Kato, Satoru Iwasa, Yasuhide Yamada
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 13:e132-e137
Aim Cetuximab improves the prognosis for wild-type KRAS metastatic colorectal cancer (MCRC). We evaluated the safety and efficacy of cetuximab in combination with irinotecan in Japanese patients with wild-type KRAS MCRC refractory to irinotecan, oxal
Autor:
Yukinori Kurokawa, Masahiro Goto, Tetsuji Terazawa, Hiroki Yukami, Hitoshi Nishitani, Toshio Shimokawa, Yoshihiro Matsubara, Toshifumi Yamaguchi, Taroh Satoh, Daisuke Sakai, Fukutaro Shimamoto, Hisato Kawakami, Takayuki Kii
Publikováno v:
Journal of Clinical Oncology. 37:144-144
144 Background: In Japan, S-1 plus cisplatin is regarded as one of the standard first line treatment of advanced gastric cancer (AGC). However, the prognosis of AGC remains dismal. The development of more effective chemotherapeutic regimen is thus wa
Autor:
Motoki Yoshida, Masahiro Goto, Ken Asaishi, Shin Kuwakado, Kazuhide Higuchi, Hitoshi Nishitani, Takahiro Miyamoto, Shinichiro Kawabe, Takayuki Kii
Publikováno v:
Digestion. 87:59-64
Background/Aim: Combination chemotherapies of oxaliplatin or irinotecan with fluoropyrimidine and molecular target drug were reported to be active in several clinical studies and so regarded as a first-line standard therapy for unresectable or metast
Autor:
Yasuhide Yamada, Takako Eguchi Nakajima, Ayumu Hosokawa, Hitoshi Nishitani, Takao Ueno, Ken Kato, Tetsuya Hamaguchi, Kohei Ogawa, Toshiro Sugiyama, Kohei Akiyoshi, Yasuhiro Shimada, Satoru Iwasa
Publikováno v:
International Journal of Clinical Oncology. 18:1020-1024
Bevacizumab, a humanized anti-vascular endothelial growth factor monoclonal antibody, has showed clinical benefits in patients with metastatic colorectal cancer. Periodontitis has been observed infrequently in bevacizumab-containing chemotherapy in c
Autor:
Sho Osuga, Shinpei Ariumi, Koichi Sohmiya, Ryo Yokoyama, Motomu Tsuji, Tatsuji Kono, Hideaki Morita, Hitoshi Nishitani, Nobukazu Ishizaka, Ryunosuke Tazaki, Yoshifumi Narumi
Publikováno v:
Internal Medicine. 51:2157-2160
Herein we report a 57-year-old man with lower extremity edema and swelling in the scrotum who was found to have a periaortic soft tissue mass and hydronephrosis by computed tomography. With the most plausible diagnosis of retroperitoneal fibrosis, co
Autor:
Hitoshi Nishitani, Takahiro Miyamoto, Tetsuji Terazawa, Takayuki Kii, Shin Kuwakado, Kazuhide Higuchi, Ken Asaishi, Masahiro Goto, Fukutaro Shimamoto
Publikováno v:
Internal medicine (Tokyo, Japan). 54(23)
Objective Recent guidelines have adopted an incidence of febrile neutropenia (FN) threshold of 20% for the use of prophylactic granulocyte colony-stimulating factor (G-CSF). In a Japanese phase II study of a combination chemotherapy regimen consistin
Autor:
Hitoshi Nishitani, Yasuhiro Shimada, Yoshinori Hirashima, Atsuo Takashima, Tetsuya Hamaguchi, Ken Kato, Yasuhide Yamada, Kuniaki Shirao, Daisuke Takahari, Shigeyuki Takeshita, Natsuko Okita
Publikováno v:
Gastric Cancer. 13:186-190
For advanced gastric cancer (AGC), second-line chemotherapy after the failure of S-1 has not yet been established. The present study aimed to retrospectively evaluate the efficacy and safety of irinotecan plus cisplatin (IP) therapy after the failure
Autor:
Takayuki Kii, Ken Asaishi, Toshifumi Yamaguchi, Hiroyuki Kodama, Masahiro Goto, Kazuhide Higuchi, Hitoshi Nishitani, Shin Kuwakado, Tetsuji Terazawa, Fukutaro Shimamoto, Masahiko Aoki
Publikováno v:
Annals of Oncology. 28:x49
Autor:
Hitoshi Nishitani, Takayuki Kii, Ken-ichi Katsu, Masahiro Gotoh, Shinichiro Kawabe, Hiroya Takiuchi, Shin Kuwakado, Toshimitsu Tanaka, Shunsuke Ohta
Publikováno v:
Japanese Journal of Clinical Oncology. 37:583-589
Background: Recently, attention has been directed to concurrent chemoradiotherapy (CRT) for the treatment of squamous cell carcinoma of the esophagus with regard to efficacy, quality of life and functional preservation, and survival periods comparabl
Autor:
Fukutaro, Shimamoto, Takayuki, Kii, Masahiro, Goto, Shin, Kuwakado, Hitoshi, Nishitani, Tetsuji, Terazawa, Ken, Asaishi, Takahiro, Miyamoto, Yoshitaka, Kurisu, Kazuhide, Higuchi
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 42(8)
A 72-year-old previously healthy man visited our hospital with complaints of hoarseness and dysphagia. Computed tomography showed wall thickening of the thoracic esophagus; invasion to the left main bronchus, aorta, and right supraclavicular lymph no